Material Agreements

Benchmark 2024-V5 Mortgage Trust entered into Midland Primary Servicing Agreement with Midland Loan Services, Wells Fargo Bank, National Association valued at Primary servicer appointment for Galleria at Tyler Mortgage Loan (effective 2024-05-06).

“As of May 6, 2024, Midland Loan Services, a Division of PNC Bank, National Association (" Midland "), will act as primary servicer of the Galleria at Tyler Mortgage Loan (the " Midland Serviced Loan ") pursuant to a Primary Servicing Agreement (the " Midland Primary Servicing Agreement "), dated as of May 1, 2024, by and between Midland and Wells Fargo Bank, National Association, in its capacity as BANK5 2024-5YR6 Master Servicer.”

Benchmark 2024-V5 Mortgage Trust entered into BANK5 2024-5YR6 PSA with J.P. Morgan Chase Commercial Mortgage Securities Corp., Wells Fargo Bank, National Association, LNR Partners, LLC, Computershare Trust Company, N.A., Park Bridge Lender Services LLC valued at Servicing of Galleria at Tyler Mortgage Loan under BANK5 2024-5YR6 PSA (effective 2024-05-06).

“The controlling Galleria at Tyler Pari Passu Companion Loan was securitized on May 6, 2024 in connection with the issuance of a series of mortgage pass-through certificates entitled BANK5 Trust 2024-5YR6, Commercial Mortgage Pass-Through Certificates, Series 2024-5YR6. Consequently, the Galleria at Tyler Mortgage Loan is being serviced and administered under the pooling and servicing agreement entered into in connection with such securitization, dated as of May 1, 2024 (the " BANK5 2024-5YR6 PSA "), between J.P. Morgan Chase Commercial Mortgage Securities Corp., as depositor, Wells Fargo Bank, National Association, as master servicer (in such capacity, the " Non-Serviced Master Servicer " or the " BANK5 2024-5YR6 Master Servicer "), LNR Partners, LLC, as special servicer (in such capacity, the " Non-Serviced Special Servicer "), Computershare Trust Company, N.A., as certificate administrator and as trustee, and Park Bridge Lender Services LLC, as operating advisor and asset representat”

Benchmark 2024-V5 Mortgage Trust entered into Pooling and Servicing Agreement with Deutsche Mortgage & Asset Receiving Corporation, Midland Loan Services, Rialto Capital Advisors, LLC, Computershare Trust Company, N.A., BellOak LLC valued at Issuance of Commercial Mortgage Pass-Through Certificates, Series 2024-V5 (effective 2024-01-31).

“On January 31, 2024, Deutsche Mortgage & Asset Receiving Corporation (the " Registrant ") caused the issuance of the Benchmark 2024-V5 Mortgage Trust (" Issuing Entity ") Commercial Mortgage Pass-Through Certificates, Series 2024-V5 (the " Certificates "), pursuant to the Pooling and Servicing Agreement, dated as of January 1, 2024 (the " Pooling and Servicing Agreement "), between the Registrant, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, Rialto Capital Advisors, LLC, as special servicer, Computershare Trust Company, N.A., as trustee, certificate administrator, paying agent and custodian, and BellOak LLC, as operating advisor and as asset representations reviewer.”

Benchmark 2024-V6 Mortgage Trust entered into Pooling and Servicing Agreement with Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, LNR Partners, LLC, as special servicer, Computershare Trust Company, National Association, as certificate administrator and as trustee, and Pentalpha Surveillance LLC, as operating advisor and as asset represent valued at Issuance of Benchmark 2024-V6 Mortgage Trust Commercial Mortgage Pass-Through Certificates, Series 2 (effective 2024-03-28).

“On March 28, 2024 (the “ Closing Date ”), GS Mortgage Securities Corporation II (the “ Depositor ”) caused the issuance of the Benchmark 2024-V6 Mortgage Trust Commercial Mortgage Pass-Through Certificates, Series 2024-V6 (the “ Certificates ”) pursuant to a pooling and servicing agreement, dated as of March 1, 2024 (the “ Pooling and Servicing Agreement ”), among the Depositor, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, LNR Partners, LLC, as special servicer, Computershare Trust Company, National Association, as certificate administrator and as trustee, and Pentalpha Surveillance LLC, as operating advisor and as asset representations reviewer.”

Apollo Asset Backed Credit Co LLC entered into Letter Agreement with Apollo Asset Management, Inc. valued at Apollo made a $50 million seed investment in the Company's E Shares at $25 per share; Apollo may req (effective 2024-05-03).

“On May 3, 2024, the Company received a seed investment from a subsidiary of Apollo Asset Management, Inc. (“Apollo”) in the form of a $50 million purchase of the Company’s E Shares in Series II (the “E Shares”) to assist the Company initiate operational and acquisition activities, at a price of $25 per share.”

Apollo Asset Backed Credit Co LLC entered into Trademark License Agreement with Apollo IP Holdings, LLC valued at License granted to use service mark, corporate name and trade name "APOLLO" (effective 2024-05-03).

“On May 3, 2024, the Company entered into a Trademark License Agreement with Apollo IP Holdings, LLC (the “Trademark License Agreement”).”

Apollo Asset Backed Credit Co LLC entered into Operating Agreement with Apollo Manager, LLC valued at Operating Agreement entered into (effective 2024-05-03).

“On May 3, 2024, Apollo Asset Backed Credit Company LLC (the “Company”) entered into an Operating Agreement (the “Operating Agreement”) with Apollo Manager, LLC (the “Operating Manager”).”

Fortrea Holdings Inc. amended Credit Amendment with Goldman Sachs Bank USA (effective 2024-05-03).

“on May 3, 2024, the Company entered into an amendment (the “Credit Amendment”) to modify certain financial covenants to provide the Company with additional flexibility under the Company’s credit agreement dated as of June 30, 2023”

Fortrea Holdings Inc. entered into Sale and Contribution Agreement with Fortrea Inc. (effective 2024-05-06).

“Pursuant to a Sale and Contribution Agreement, dated as of the Closing Date, (the “Sale and Contribution Agreement”), among the Originator, the Servicer and the SPE, the Originator will sell or contribute accounts receivable and certain related assets”

Fortrea Holdings Inc. entered into Receivables Purchase Agreement with PNC Bank, National Association valued at $300 million (effective 2024-05-06).

“On May 6, 2024 (the “Closing Date”), Fortrea Holdings Inc. (the “Company”), Fortrea Receivables LLC, a special purpose entity (the “SPE”) that is a wholly-owned indirect subsidiary of the Company, and Fortrea Inc., as originator (the “Originator”) and servicer (the “Servicer”), entered into a three-year, $300 million receivables securitization program”

Ivanhoe Electric Inc. entered into Compensation Letter with Robert Friedland valued at $500,000 per year (effective 2024-05-09).

“On May 9, 2024, Ivanhoe Electric Inc. (the “Company”) entered into a compensation and change of control arrangement with Robert Friedland with respect to his services as the Executive Chairman of the Company.”

Zoomcar Holdings, Inc. entered into White Lion Registration Rights Agreement with White Lion Capital LLC valued at Agreement to file a resale registration statement covering the resale by White Lion of shares (effective 2024-05-06).

“Concurrently with the Common Stock Purchase Agreement, the Company entered into the White Lion RRA with White Lion, in which the Company agreed to file, within 10 days following the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, a resale registration statement with the SEC covering the resale by White Lion of the maximum number of shares permitted to be included thereon in accordance with applicable SEC rules, regulations and interpretations.”

Zoomcar Holdings, Inc. entered into Common Stock Purchase Agreement with White Lion Capital LLC valued at Up to $25,000,000 in aggregate gross purchase price of newly issued shares of Common Stock, and an a (effective 2024-05-06).

“On May 6, 2024, by Zoomcar Holdings, Inc. (the “ Company ”) entered into a common stock purchase agreement (the “ Common Stock Purchase Agreement ”) and a related registration rights agreement (the “ White Lion RRA ”) with White Lion Capital LLC (“ White Lion ”).”

LanzaTech Global, Inc. entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc. valued at up to $100 million (effective 2024-05-09).

“On May 9, 2024, LanzaTech Global, Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) and a Terms Agreement (the “Terms Agreement” and, together with the Sales Agreement, the “ATM Agreements”) with B. Riley Securities, Inc. (“B. Riley Securities”), pursuant to which the Company may, from time to time, offer and sell shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), having an aggregate offering price of up to $100 million (the “Shares”).”

Nogin, Inc. entered into Equity Purchase Agreement with Nogin Holdings, LLC (effective 2024-04-26).

“On April 26, 2024, Nogin, Inc. (the “Company”) and Nogin Commerce, Inc. (“Nogin Commerce”), its operating subsidiary, entered into an Equity Purchase Agreement (the “Equity Purchase Agreement”) with Nogin Holdings, LLC, as the purchaser (the “Purchaser”), and B. Riley Financial, Inc. (solely with respect to its obligations as the Purchaser Parent as set forth in the Equity Purchase Agreement).”

eFFECTOR Therapeutics, Inc. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2024-05-09).

“On May 9, 2024, the Company terminated its Controlled Equity Offering SM Sales Agreement, dated September 1, 2022, with Cantor Fitzgerald & Co. (the “Prior Sales Agreement”), pursuant to which the Company was able sell shares of common stock in “at the market offerings” as defined by Rule 415 of the Securities Act.”

eFFECTOR Therapeutics, Inc. entered into Sales Agreement with H.C. Wainwright & Co., LLC valued at up to $50.0 million (effective 2024-05-09).

“On May 9, 2024, eFFECTOR Therapeutics, Inc. (the “Company”) entered into an At the Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Agent”), under which the Company may, from time to time, sell shares of the Company’s common stock having an aggregate offering price of up to $50.0 million through the Agent.”

eFFECTOR Therapeutics, Inc. terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. valued at $9.8 million (effective 2024-05-09).

“On May 9, 2024, the Company terminated its Controlled Equity Offering SM Sales Agreement, dated September 1, 2022, with Cantor Fitzgerald & Co. (the “Prior Sales Agreement”), pursuant to which the Company was able sell shares of common stock in “at the market offerings” as defined by Rule 415 of the Securities Act.”

eFFECTOR Therapeutics, Inc. entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC valued at aggregate offering price of up to $50.0 million (effective 2024-05-09).

“On May 9, 2024, eFFECTOR Therapeutics, Inc. (the “Company”) entered into an At the Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Agent”), under which the Company may, from time to time, sell shares of the Company’s common stock having an aggregate offering price of up to $50.0 million through the Agent.”

GPGI, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., TD Securities (USA) LLC (effective 2024-05-08).

“On May 8, 2024, CompoSecure, Inc. (the “ Company ”) and CompoSecure Holdings, L.L.C. (the “ Operating Subsidiary ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with J.P. Morgan Securities LLC (“ J.P. Morgan ”), BofA Securities, Inc. (“ BofA ”), and TD Securities (USA) LLC (“ Cowen ”) as the representatives”

TILT Holdings Inc. entered into Secured Promissory Note with a third party experienced retailer and operator (the "Lender") valued at up to $10,500,000 (effective 2024-05-02).

“On May 2, 2024, Standard Farms LLC, a Pennsylvania limited liability corporation (“Standard Farms”) and a subsidiary of TILT Holdings Inc., entered into a Secured Promissory Note (the “Note”).”

LINKBANCORP, Inc. entered into Agreement with American Heritage Federal Credit Union valued at approximately $123.0 million in loans, three branch locations (along with associated personal proper (effective 2024-05-09).

“On May 9, 2024, LINKBANK, the banking subsidiary of LINKBANCORP, Inc. (the “Company”) entered into a purchase and assumption agreement (the “Agreement”) with American Heritage Federal Credit Union (“AHFCU”) pursuant to which AHFCU will purchase certain assets and assume certain liabilities (the “Transaction”) of the New Jersey operations of LINKBANK, including all three branch locations (including two branch leases).”

Fathom Holdings Inc. entered into Equity Purchase Agreement with D6 Holdings, LLC valued at $15 million in cash (effective 2024-05-03).

“On May 3, 2024, E4:9 Holdings, Inc. (the “Seller”), a wholly-owned subsidiary of Fathom Holdings Inc. (“Fathom”), entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Dagley Insurance Agency, LLC, a wholly-owned operating subsidiary of the Seller (“DIA”), D6 Holdings, LLC, (the “Purchaser”), and Nathan Dagley, owner of Purchaser and founder and president of DIA.”

Alzamend Neuro, Inc. entered into Securities Purchase Agreement with a sophisticated investor valued at up to $25,000,000.00 (effective 2024-05-08).

“On May 8, 2024 (the “ Execution Date ”), Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”) entered into a Securities Purchase Agreement (the “ Agreement ”) with a sophisticated investor (the “ Purchaser ”), pursuant to which the Company agreed to sell to the Purchaser up to 2,500 shares of Series A Convertible Preferred Stock (the “ Series A Preferred Stock ”) and warrants (the “ Warrants ”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) for a total purchase price of up to $25,000,000.00 (the “ Financing ”) in several tranche closings”

Verona Pharma plc entered into Credit Agreement with Oaktree Capital Management, L.P. and OCM Life Sciences Portfolio LP valued at up to $400.0 million (effective 2024-05-09).

“On May 9, 2024 (the “Effective Date”), Verona Pharma, Inc. (the “Borrower”), a wholly-owned subsidiary of Verona Pharma plc (the “Company”), entered into a term loan facility of up to $400.0 million (the “Term Loan”), consisting of a term loan advance in an aggregate amount of $55.0 million to be funded on the Effective Date (the “Tranche A Term Loan”), a term loan advance to be borrowed within eight business days after the occurrence of certain terms and conditions in an aggregate amount of $70.0 million (the “Tranche B Term Loan”), a term loan advance available subject to certain terms and conditions in an aggregate amount of $75.0 million (the “Tranche C Term Loan”), a term loan advance available subject to certain terms and conditions in an aggregate amount of $100.0 million (the “Tranche D Term Loan”) and a term loan advance available in the sole discretion of the lenders and subject to certain terms and conditions in an aggregate amount of up to $100.0 million (the “Tranche E Ter”

Atlassian Corp entered into Underwriting Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters valued at $500 million aggregate principal amount of 5.250% senior notes due 2029 and $500 million aggregate p (effective 2024-05-08).

“On May 8, 2024, Atlassian Corporation (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with BofA Securities, Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), providing for its underwritten public offering (the “ Notes Offering ”) of $500 million aggregate principal amount of 5.250% senior notes due 2029 (the “ 2029 Notes ”) and $500 million aggregate principal amount of 5.500% senior notes due 2034”

GMF Leasing LLC entered into Underwriting Agreement with BMO Capital Markets Corp., BofA Securities, Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, RBC Capital Markets, LLC (the Representatives), BNP Paribas Securities Corp., CIBC World Markets Corp., MUFG Securities Americas Inc., Scotia Capital (USA) Inc. (the Underwriters) valued at $188,680,000 Class A-1 5.531% Asset Backed Notes, $294,480,000 Class A-2-A 5.43% Asset Backed Notes, (effective 2024-05-07).

“the Underwriting Agreement attached hereto as Exhibit 1.1 , dated as of May 7, 2024 (the " Underwriting Agreement "), among GM Financial, the Depositor and the Representatives.”

Solana Co entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC valued at approximately $6.4 million (effective 2024-05-06).

“On May 6, 2024, Helius Medical Technologies, Inc., (the “Company”), entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC (the “Placement Agent”) for the purchase and sale, in a registered public offering by the Company (the “Public Offering”) of 704,999 shares of its Class A common stock, par value $0.001 per share (“Common Stock”) and 2,147,222 pre-funded warrants, each to purchase one share of Common Stock at an exercise price of $0.001 per share (the “Pre-funded Warrants”) together with accompanying Series A Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series A Warrants”) and Series B Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series B Warrants”, and together with the Series A Warrants, the “Public Warrants”).”

PlayAGS, Inc. entered into Agreement and Plan of Merger with Bingo Holdings I, LLC and Bingo Merger Sub, Inc. (effective 2024-05-08).

“On May 8, 2024, PlayAGS, Inc., a Nevada corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Bingo Holdings I, LLC, a Delaware limited liability company (“Parent”) and an affiliate of Brightstar Capital Partners, and Bingo Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Parent (“Merger Sub"), providing for, among other things, the merger of Merger Sub with and into the Company”

Enviva Inc. entered into DIP Credit Agreement with the various lenders from time to time party thereto, Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents, and Acquiom, as collateral agent valued at $500,000,000 (effective 2024-03-15).

“On March 15, 2024, the Debtors entered into a Debtor-in-Possession Credit and Note Purchase Agreement (the “ DIP Credit Agreement ”) by and among the Company, as borrower, and the other Debtors, as guarantors, the various lenders from time to time party thereto (the “ Lenders ”), and Acquiom Agency Services LLC (“ Acquiom ”) and Seaport Loan Products LLC, as co-administrative agents, and Acquiom, as collateral agent providing for a debtor-in-possession term loan and notes facility (the “ DIP Financing ”) in an amount not to exceed $500,000,000.”

Caesars Entertainment, Inc. amended Fourth Amendment to Credit Agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (effective 2024-05-09).

“On May 9, 2024, Caesars Entertainment, Inc. (the “Company”), a Delaware corporation, entered into a Fourth Amendment to Credit Agreement (the “Amendment”), by and among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”).”

Greenwave Technology Solutions, Inc. amended Waiver Agreement with certain institutional investors (effective 2024-05-09).

“On May 9, 2024, the Company and the Investors entered into a Waiver Agreement (the “Waiver Agreement”), pursuant to which the Company and the Investors decided to waive the Conversion Prohibition in the March Consent and Waiver.”

Coherus Oncology, Inc. terminated Prior Loan Agreement valued at $75 million (effective 2024-05-08).

“In connection with the entry into the Loan Agreement, on the Effective Date, the Company repaid in full all outstanding indebtedness and terminated all commitments under the Prior Loan Agreement, the material terms of which have been disclosed previously.”

Coherus Oncology, Inc. entered into Revenue Purchase and Sale Agreement with Coduet Royalty Holdings, LLC, as administrative agent and each buyer named in an annex thereto valued at $37.5 million (effective 2024-05-08).

“On May 8, 2024, the Company entered into a revenue participation right purchase and sale agreement (the “Revenue Purchase and Sale Agreement”) with Coduet Royalty Holdings, LLC, as administrative agent and each buyer named in an annex thereto (collectively, the “Purchaser”).”

Coherus Oncology, Inc. entered into Loan Agreement with Ankura Trust Company, LLC, as administrative agent, and the lenders signatory thereto valued at $38.7 million (effective 2024-05-08).

“On May 8, 2024, Coherus BioSciences, Inc., a Delaware corporation (the “Company”), entered into a senior secured term loan facility of up to $38.7 million (the “Term Loan”), all to be funded on May 8, 2024 (the “Effective Date”), with Ankura Trust Company, LLC, as administrative agent (in such capacity, the “Agent”), and the lenders signatory thereto (collectively, the “Lenders”).”

Block, Inc. entered into Indenture with Bank of New York Mellon Trust Company, N.A. valued at 6.50% Senior Notes due 2032, $2.0 billion aggregate principal amount (effective 2024-05-09).

“On May 9, 2024, the Company entered into an indenture relating to the issuance of the Notes (the “Indenture”), by and between the Company and the Bank of New York Mellon Trust Company, N.A. (the “Trustee”), as trustee of the Notes.”

Block, Inc. entered into Purchase Agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC valued at $2.0 billion aggregate principal amount of 6.50% Senior Notes due 2032 (effective 2024-05-06).

“On May 6, 2024, Block, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the several initial purchasers listed in Schedule I therein (the “Initial Purchasers”), relating to the sale by the Company of $2.0 billion in aggregate principal amount of its 6.50% Senior Notes due 2032 (the “Notes”) in private placements to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act.”

SILVERTON ENERGY, INC. entered into Agrawal Acquisition Agreement with Kris Agrawal and Kris K. Agrawal, et al, Exxon Oil & Gas, Inc., Vance-1 Properties, LLC valued at $3,500,000 purchase price payable via convertible note convertible into Class A Common Stock (effective 2024-04-04).

“On May 01, 2024, the Company entered into an "Acquisition Agreement" between AHIC and SLTN, as the "Buyer" and Kris Agrawal and Kris K. Agrawal, et al, Exxon Oil & Gas, Inc., Vance-1 Properties, LLC, as the "Seller" (the Agrawal Acquisition Agreement"), with an effective date of April 04, 2024 [ see EX 2.01B ].”

SILVERTON ENERGY, INC. entered into Agrawal Acquisition Agreement with Kris Agrawal and Kris K. Agrawal, et al, Exxon Oil & Gas, Inc., Vance-1 Properties, LLC valued at $3,500,000.00 (effective 2024-04-04).

“On May 01, 2024, the Company entered into an "Acquisition Agreement" between AHIC and SLTN, as the "Buyer" and Kris Agrawal and Kris K. Agrawal, et al, Exxon Oil & Gas, Inc., Vance-1 Properties, LLC, as the "Seller" (the Agrawal Acquisition Agreement"), with an effective date of April 04, 2024”

SILVERTON ENERGY, INC. entered into AHIC Acquisition Agreement with American Heritage Investment Capital, LP. ("AHIC") valued at $81,000,000 (effective 2024-05-01).

“On May 01, 2024, the Company entered into an "Acquisition Agreement" between the Company as the Buyer, and American Heritage Investment Capital, LP. ("AHIC"), (the "AHIC Acquisition Agreement"”

X4 Pharmaceuticals, Inc entered into Asset Purchase Agreement with not specified valued at $105,000,000 (effective 2024-05-08).

“On May 8, 2024, X4 Pharmaceuticals, Inc. (the “Company”), entered into an asset purchase agreement (the “Asset Purchase Agreement”) to sell a Rare Pediatric Disease Priority Review Voucher (“PRV”) for a lump sum payment of $105.0 million, payable in cash upon the closing of the sale, which occurred simultaneously with the parties entering into the Asset Purchase Agreement.”

OptiNose, Inc. entered into Third Amendment to Amended and Restated Note Purchase Agreement with BioPharma Credit PLC, as collateral agent, and the purchasers party thereto valued at waiver of going concern qualification, reduction of minimum cash from $30M to $20M, issuance of 4,68 (effective 2024-05-08).

“On May 8, 2024, the Company entered into a Third Amendment (the “Third Amendment”) to that certain Amended and Restated Note Purchase Agreement, dated November 21, 2022, and amended on March 5, 2024 and March 8, 2024, among the Company and its subsidiary, OptiNose US, Inc., BioPharma Credit PLC, as collateral agent, and the purchasers party thereto from time to time.”

OptiNose, Inc. entered into Securities Purchase Agreement with purchasers named therein valued at aggregate gross proceeds expected to be approximately $55 million (effective 2024-05-08).

“On May 8, 2024, OptiNose, Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreement”) pursuant to which it agreed to issue and sell to the purchasers named therein an aggregate of (i) 31,800,000 shares (the “Shares”) of the Company’s common stock (“Common Stock”) at a purchase price of $1.00 per Share and (ii) in lieu of shares of Common Stock to certain investors, pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 23,700,000 shares of Common Stock (the “Pre-Funded Warrant Shares” and, together with the Shares and the Pre-Funded Warrants, the “Securities”) at a price of $0.999 per Pre-Funded Warrant, which represents the per share price for the Shares less the $0.001 per share exercise price for each such Pre-Funded Warrant (the foregoing collectively referred to as the “Registered Direct Offering”).”

MOBIVITY HOLDINGS CORP. amended Amendment No. 2 to Amended and Restated Credit Facility Agreement and Convertible Notes with Thomas B. Akin (effective 2024-05-03).

“On May 3, 2024, Mobivity Holdings Corp. (the “Company”) entered into Amendment No. 2 (the “Amendment”) to Amended and Restated Credit Facility Agreement and Convertible Notes”

SS&C Technologies Holdings Inc entered into Incremental Joinder & First Amendment to Credit Agreement with Morgan Stanley Senior Funding, Inc. (effective 2024-05-09).

“On May 9, 2024, SS&C Technologies, Inc. (the “Term B-8 Borrower”) entered into the Incremental Joinder & First Amendment to Credit Agreement (the “Amendment”), which amends its existing amended and restated credit agreement, dated as of April 16, 2018 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Term B-8 Borrower, SS&C Financing LLC, SS&C European Holdings SARL and SS&C Technologies Holdings Europe SARL, as the borrowers, Morgan Stanley Senior Funding, Inc., as the administrative agent, certain lenders party thereto and the other parties from time to time party thereto.”

SS&C Technologies Holdings Inc entered into Indenture with Wilmington Trust, National Association valued at $750 million aggregate principal amount (effective 2024-05-09).

“On May 9, 2024, SS&C Technologies, Inc. (the “Issuer”), a direct, wholly-owned subsidiary of SS&C Technologies Holdings, Inc. (the “Parent”), issued $750 million aggregate principal amount of 6.500% Senior Notes due 2032 (the “Notes”), at a price equal to 100% of their face value, pursuant to an indenture, dated as of May 9, 2024 (the “Indenture”), among the Issuer, the Parent, the other guarantors party thereto (together with the Parent, the “Guarantors”) and Wilmington Trust, National Association, as trustee.”

Cheniere Energy Partners, L.P. entered into Purchase Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., ING Financial Markets LLC, MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc. and Standard Chartered Bank, as representatives of the initial purchasers valued at $1,200,000,000 aggregate principal amount of its 5.750% Senior Notes due 2034 (effective 2024-05-08).

“with BofA Securities, Inc., Citigroup Global Markets Inc., ING Financial Markets LLC, MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc. and Standard Chartered Bank, as representatives of the initial purchasers named therein”

GUGGENHEIM STRATEGIC OPPORTUNITIES FUND amended Fourth Amendment to Controlled Equity Offering SM Sales Agreement with Guggenheim Funds Investment Advisors, LLC and Cantor Fitzgerald & Co. valued at up to $850,000,000 (effective 2024-05-03).

“Guggenheim Strategic Opportunities Fund (NYSE: GOF) (the “Fund”) has entered into a Controlled Equity Offering SM Sales Agreement, dated July 1, 2019, as amended by First Amendment to Controlled Equity Offering SM Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering SM Sales Agreement, dated September 16, 2021, Third Amendment to Controlled Equity Offering SM Sales Agreement, dated March 27, 2023, and Fourth Amendment to Controlled Equity Offering SM Sales Agreement, dated May 3, 2024 (as amended, the “Sales Agreement”), by and among the Fund, Guggenheim Funds Investment Advisors, LLC, and Cantor Fitzgerald & Co. (“Cantor Fitzgerald”)”

HALLMARK VENTURE GROUP, INC. entered into On Demand Promissory Note Agreement with independent privately-held non-affiliated third party valued at $100,000 (implied 8% interest) (effective 2024-05-02).

“On May 2, 2024, the Company subsequently made a strategic loan with an independent privately-held non-affiliated third party by entering into a 180 day 8% On Demand Promissory Note Agreement.”

HALLMARK VENTURE GROUP, INC. entered into Warrant Subscription Agreement with Nicosel, LLC valued at 100,000 warrants (effective 2024-05-01).

“On May 1, 2024, Hallmark Venture Group, Inc (the “Company”) issued a $100,000, 8% Convertible Promissory Note (the “Note”) and entered into a Warrant Subscription Agreement with Nicosel, LLC , a non-affiliate of the Company.”